Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
7.39
+0.18 (2.50%)
Oct 9, 2026, 1:24 PM EDT - Market open
MRVI Market Cap
MRVI has a market cap or net worth of $1.92 billion as of October 9, 2026. It is the 7,070th most valuable company in the world and the 1,820th biggest in the United States. Its market cap has increased by 125.66% in one year.
Market Cap
1.92B
Enterprise Value
2.07B
1-Year Change
125.66%
Global Rank
Country Rank
#1,820 United States
Category
ChartMarket Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $7.23B to $1.92B, a decrease of -73.46%. That is a compound annual growth rate of -20.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 1.92B | 130.93% |
| Dec 31, 2025 | 831.00M | -39.62% |
| Dec 31, 2024 | 1.38B | -16.38% |
| Dec 29, 2023 | 1.65B | -54.93% |
| Dec 30, 2022 | 3.65B | -66.18% |
| Dec 31, 2021 | 10.80B | 49.29% |
| Dec 31, 2020 | 7.23B | 0.01% |
| Nov 20, 2020 | 7.23B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vera Therapeutics | 2.11B |
| Aurinia Pharmaceuticals | 2.10B |
| Viridian Therapeutics | 2.08B |
| Vericel | 2.05B |
| ADARx Pharmaceuticals | 2.03B |
| UroGen Pharma | 2.00B |
| Vir Biotechnology | 1.96B |
| Fortrea Holdings | 1.96B |